Constraint-Aware Corrective Memory for Language-Based Drug Discovery Agents
Large language models are making autonomous drug discovery agents increasingly feasible, but reliable success in this setting is not determined by any single action or molecule. It is determined by whether the final returned set jointly satisfies protocol-level requirements such ...
ArXiv CS.AI
Source
Generated insight by OnAirToday AI
This research tackles a critical control problem in AI-driven drug discovery: ensuring the final set of drug candidates meets complex, multi-faceted criteria. By introducing Constraint-Aware Corrective Memory (CACM), the system significantly improves success rates by enabling precise diagnosis of protocol violations and generating actionable remediation hints for the agent, making autonomous discovery more reliable.

Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.